■ Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leucemia
Meinolf Suttorp, Frédéric Millot, Stephanie Sembill et al
Cancers (Basel) 2021, vol 13(4): 798
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917817/
■ Thrombocytosis in children and adolescents – classification, diagnostic approach, and clinical management
Clemens Stockklausner, C. M. Duffert, H. Cario et al
On behalf of THROMKID-Plus Studiengruppe der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) and of Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH)
Ann Hematol 2021; vol 100(7): 1647–1665
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195939/
■ Risk and response adapted treatment guidelines for managing relapsed and refractory classical Hodgkin lymphoma in children and young people. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
S Daw, D Hasenclever, M Mascarin et al
Hemasphere 2021, vol 4 (1): e329
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7000476/
■ Iron deficiency anemia in children residing in high and low-income countries: risk factors, prevention, diagnosis and therapy
Elpis Mantadakis, Eleftherios Chatzimichael, Panagiota Zikidou
Mediterr J Hematol Infect Dis.2020; vol 12(1): e2020041
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7340216/
■ Interventions for addressing anemia among children and adolescente: an overview of systematic reviews
Prasanna Mithra, Mahalaqua Nazli Khatib, Anju Pradhan Sinha et al
Front Pediatr.2020; vol 8: 549549
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7921152/
■ Immunization adherence in children with sickle cell disease: a single-institution experience
Lisa M. Infanti, Joshua J. Elder, Kyle Franco et al
J Pediatr Pharmacol Ther.2020, vol 25(1): 39–46
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938294/
■ Review and emerging targeted therapies for pediatric acute myeloid leucemia (AML)
Jing Chen, Chana L. Glasser
Children (Basel) 2020, vol 7(2): 12
https://www.mdpi.com/2227-9067/7/2/12/htm
■ Advances in pediatric acute promyelocytic leukemia
Shannon E. Conneely, Alexandra M. Stevens
Children (Basel) 2020, vol 7(2): 11
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7072343/
■ Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia
Seth E. Karol, Ching-Hon Pui
Ther Adv Hematol 2020, vol 11:2040620720927575.
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7268159/
■ Harnessing T cells to target pediatric acute myeloid leucemia: CARs, BiTEs, and beyond
Rebecca Epperly, Stephen Gottschalk, Mireya Paulina Velasquez
Children (Basel) 2020, vol 7(2): 14
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7072334/
■ Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa
Nmazuo W. Ozuah, Joseph Lubega, Carl E. Allen, Nader Kim El-Mallawany
Blood Adv 2020, vol 4(16): 4007–4019
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448606/
■ Manejo analgésico da crise dolorosa falciforme não complicada em pediatria: uma revisão sistemática e metanálise.
Saramba, Manou Irmina, Shakya, Sandeep and Zhao, Dongchi
- Pediatr. (Rio J.), Apr 2020, vol.96, no.2, p.142-158
https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572020000200142&lng=pt&nrm=iso&tlng=pt (portuguese)
■ Risk and response adapted treatment guidelines for managing relapsed and refractory classical Hodgkin lymphoma in children and young people. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
S Daw, D Hasenclever, M Mascarin et al
Hemasphere 2021, vol 4 (1): e329
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7000476/
■ Gene therapy of the hemoglobinopathies
J B Kunz, A E Kulozik
Hemasphere 2020, vol 4 (5): e479
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7489710/
■ Venous thromboembolism in childhood: where is Brazil after 20 years
T T Mello, H D A Carneiro, G A Mello, J M A Bizzacchi
Hematol, Trans. Cell Ther 2020, vol 42 (1)
https://www.scielo.br/j/htct/a/6Cth9CkCZ7fs3WZjhvxDfcp/?lang=en
■ Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population
F Carobolante, S Chiaretti, C Skert, R Bassan
Ther Adv Hematol 2020, vol 11: 2040620720903531
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6997963/
■ Fetal hemoglobina in sickle hemoglobinopathies: high HbF genotype and phenotypes
Martin H. Steinberg
J Clin Med.2020, vol 9(11): 3782
https://ashpublications.org/blood/article/118/1/19/28401/Fetal-hemoglobin-in-sickle-cell-anemia
■ Current issues and options ,for hormonal contraception in adolescents and young adult women with sickle cell disease: an update for health care professionals
Vincenzo De Sanctis, Ashraf T. Soliman, Shahina Daar et al
Mediterr J Hematol Infect Dis.2020; vol 12(1): e2020032.
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7202337/
■ Bleeding complications after pediatric kidney biopsy: a systematic review and meta-analysis
Charles D. Varnell, Jr., Hillarey K. Stone, Jeffrey A. Welge
Clin J Am Soc Nephrol 2019, vol 14(1): 57–65
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364534/
■ Pulmonary hemosiderosis in children with Down syndrome: a national experience
Aurelia Alimi, Jessica Taytard, Rola Abou Taam et al
Orphanet J Rare Dis.2018; vol 13: 60
https://ojrd.biomedcentral.com/articles/10.1186/s13023-018-0806-6
■ Deficiência de ferro na criança
J A P Braga, M S S Vitalle
Rev Bras Hematol Hemot 2010, vol 32 (suppl 2)
https://www.scielo.br/j/rbhh/a/QWdTYfPCzqVNKjTWHjmGw3M/?lang=pt
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Blog Internet Médica – www.internetmedica.com.br
Data: novembro 2021